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Aims Enhanced external counter pulsation (EECP) is a non-invasive and non-pharmacological therapy for
patients with symptomatic coronary artery disease (CAD). There are, however, insufﬁcient data to
support the effectiveness of EECP in improving the myocardial mechanical properties of patients with
refractory stable angina. We aimed to assess the effects of EECP on myocardial mechanical properties
and cardiac functions in CAD patients not eligible for surgical or percutaneous revascularization
procedures.
Methods and results Twenty patients in New York Heart Association (NYHA) functional Class III and IV
angina were evaluated. The mean age of the patients was 63+9 years, and 65% were male. A compre-
hensive echocardiographic study including an evaluation of the tissue Doppler-based parameters of sys-
tolic and diastolic functions was performed before and after the termination of the protocol. EECP was
carried out 1 h per day, 5 days per week, for 7 weeks. EECP resulted in a signiﬁcant increase in peak late
diastolic transmitral inﬂow velocity (0.75+0.14 vs. 0.83+0.20 m/s, P, 0.05), propagation
velocity (42.35+6.25 vs. 46.00+5.68 cm/s, P, 0.05), peak early diastolic velocity of mitral
annulus (5.35+1.79 vs. 5.95+1.10 cm/s, P , 0.05), peak systolic velocity (2.51+0.28 vs. 2.67+
0.26, P, 0.05), and early diastolic velocity (3.24+0.18 vs. 3.52+0.26 cm/s, P , 0.01) of all
middle segments, peak late diastolic velocity of all basal (4.48+0.58 vs. 4.75+0.70 cm/s, P, 0.05)
and middle segments (2.82+0.66 vs. 3.25+0.46 cm/s, P , 0.01), peak systolic strain rate of all
basal (0.76+0.07 vs. 0.99+0.08 1/s, P ¼ 0.001) and middle segments (0.75+0.09 vs. 0.94+0.09
1/s, P, 0.001), peak systolic strain of basal (11.64+1.51 vs. 13.97+1.52%, P, 0.01) and middle seg-
ments (11.81+1.15 vs.13.73+1.57%, P , 0.001), and left ventricular (LV) ejection fraction (40.25+
12.72 vs. 46.25+12.97%, P , 0.001).There was also a signiﬁcant decrease in the ratios of transmitral
E/A (0.92+ 0.41 vs. 1.08+ 0.46, P , 0.05) and E/Ea (12.61+4.22 vs. 15.44+6.96, P, 0.05) after
EECP therapy. A signiﬁcant reduction in NYHA angina class ( 1 angina class) was seen in the patients,
who completed treatment.
Conclusion EECP therapy seemed to improve both regional and global LV systolic and diastolic functions
in patients with chronic angina pectoris.
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Coronary artery disease (CAD) is a leading cause of death and
disability worldwide. Chronic myocardial ischaemia resulting
from CAD can cause stable angina and interfere with ordinary
activities.1 Treatment of CAD consists of medical and invasive
surgical and non-surgical coronary interventions.2 However,
there are patients who are not suitable candidates for coro-
nary interventions and are symptomatic despite aggressive
medical treatment.3,4 The search for alternative therapies
for this subgroup of patients has recently yielded some new
treatment modalities such as enhanced external counter pul-
sation (EECP).5 EECP is a non-invasive, outpatient therapy for
the treatment of chronic angina pectoris patients who have
not responded to pharmacotherapy and are not candidates
for surgical or percutaneous revascularization procedures,
e.g. angioplasty and coronary bypass surgery.6,7 The haemo-
dynamic effects of EECP are similar to those of intra-aortic
balloon pumping8 (IABP) but in contrast to IABP, EECP provides
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long-lasting increase in the coronary blood ﬂow.9,10 EECP has
been demonstrated to be effective in some disorders11
inasmuch as it boosts myocardial perfusion, enhances
dipyridamole-induced coronary vasodilatation, and increases
the time to 1-mm ST-segment depression, which can ulti-
mately reduce both angina and myocardial ischaemia in
patients not responding to medical and surgical therapy.12
Be that as it may, the exact mechanism whereby EECP
exerts its favourable effects has hitherto remained
unclear,11 and there is insufﬁcient evidence to support the
effectiveness of EECP treatment in myocardial function.6
Strain rate imaging has been derived from regional velo-
city gradients within the myocardium aligned along the
Doppler beam.13,14 Strain rate measures the rate of the
deformation of a tissue segment, and peak systolic and dia-
stolic strain rate represents the maximal rate of defor-
mation in systole and diastole. Strain is obtained by
integrating strain rate over time and represents the defor-
mation of a tissue segment over time, and end-systolic
strain represents the magnitude of peak deformation in
systole. A spatial map of longitudinal deformation within
the myocardium can be obtained with this method.
The present study sought to evaluate the effects of EECP
therapy on both global and regional left ventricular (LV)
systolic and diastolic functions of intractable angina patients
not amenable to medical treatment or percutaneous revas-
cularization procedures.
Methods
Study patients
We studied 20 patients, comprising 13 men and 7 women aged
between 45 and 78 years (mean 63+9 years), with severe anginal
symptoms secondary to chronic CAD, none of them were candidate
for revascularization therapy. The majority of patients (90%) had
multi-vessel disease. The inclusion criteria were New York Heart
Association (NYHA) Class III or IV angina despite aggressive pharma-
cotherapy. All medications (except for TNG PRN) remained
unchanged. We excluded the patients with poor strain/strain
curves in more than two segments. The patients were questioned
about any adverse reaction and improvement of angina. All the sub-
jects were studied after written informed consent had been
obtained in accordance with the regulations of the ethics commit-
tee of Shaheed Rajaie Cardiovascular Medical and Research
Center, Tehran, Iran.
Study protocol used for EECP treatment
The EECP device (Figure 1) consists of three paired pneumatic cuffs
applied to the lower extremities (Vasomedical, Westbury, NY, USA).
Patients are typically treated for a 1-h daily programme for a total
of 35 sessions over 7 weeks. Three sets of pneumatic cuffs, wrapped
around the patient’s calves, lower thighs, and upper thighs
(Figure 2). The cuffs are inﬂated sequentially at the onset of dia-
stole, and 300 mmHg of external pressure is applied during diastole.
At the onset of systole, the external pressure in the cuffs is
released, producing a decrease in systolic pressure. A computer-
controlled pneumatic system with a display console is used to
inﬂate and deﬂate the series of compressive cuffs, and inﬂation
and deﬂation are triggered by events in the cardiac cycle through
microprocessor-interpreted electrocardiography signals. The com-
pression is triggered by the electrocardiographic R-wave, with the
delay being adjusted until the induced retrograde pulse wave
enhances the cardiac output as reﬂected by an optimally augmen-
ted blood pressure and blood ﬂow wave during cardiac diastole.15,16
A ﬁnger plethysmogram is utilized throughout treatment to monitor
diastolic and systolic pressure wave forms (Figure 1).6Figure 1 Enhanced external counter pulsation device.
Figure 2 Mechanism of EECP. Schematic of EECP showing sequential cuff inﬂation and deﬂation. EECP induced by successive compression of
cuffs wrapped around the calves, thighs, and buttocks. Rhythmical, 250-mmHg compression during diastole is optimized by adjusting the
delay between the electrocardiographic R-wave and the compression onset until a ﬁnger-plethysmographic pulse curve shows a blood
pressure augmentation during diastole above systolic blood pressure values.
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Echocardiography examinations
Echocardiography examinations were done before and after EECP
using Vivid seven digital ultrasound scanner equipment with an
ergonomically designed multi-frequency M3S transthoracic sector
transducer and tissue velocity imaging facility.
LV systolic and diastolic function parameters were measured. LV
diastolic function was assessed via conventional PW Doppler of the
mitral inﬂow including early (E) and late (A) transmitral diastolic
velocities, E/A ratio, isovolumetric relaxation time (IVRT), decel-
eration time (DT), A-wave duration, E/Ea ratio, propagation
velocity, pulmonary veins ﬂow velocities, and peak ﬁlling rate.
IVRT was recorded as the interval between aortic valve closure
and mitral valve opening. Greyscale images were recorded in
second harmonic mode with 1.7 MHz as transmit frequency. LV ejec-
tion fraction (LVEF) was assessed via eyeball evaluation and via
Simpson’s method if accurate endocardial border detection was
possible.17
Tissue Doppler, strain, and strain rate imaging and
data analysis
Colour Doppler myocardial imaging (CDMI) from the interventricular
septum, lateral, anterior, inferior, anteroseptal, and posterior walls
were recorded using the apical 4-, 2-, and 3-chamber views with the
subjects in left lateral decubitus position according to the rec-
ommendations of the American Society of Echocardiography,18
pre- and post-EECP treatment. All data sets were acquired over
three consecutive heartbeats at high frame rate (130–180 frames/
s) using a 2.4 MHz transducer. In all acquisitions, the 2D-sector
angle was minimized to attain a high frame rate, and the pulse rep-
etition frequency was adjusted in order to avoid aliasing. Aortic
valve opening and closing times and also mitral valve opening and
closing times were measured using systolic aortic blood ﬂow and
diastolic mitral blood ﬂow recording via pulsed Doppler with the
sample volume placed at the level of the aortic annulus and
mitral valve tip, respectively. The digital cineloops raw data sets
containing both grey scale and tissue velocity imaging information
were stored in the scanner memory for off-line analysis. After the
completion of the echocardiographic examinations via CDMI, the
raw data were analysed off-line using the Vivid seven system to
obtain regional myocardial velocity, strain, and strain rate imaging
proﬁles in all LV base and mid segments in the myocardial location
using an 8  4 region of interest (ROI). Information on a total of
12 base and mid segments throughout the 3 end-expiratory beats
was recorded and analysed for each patient. The following data
were measured in each patient pre- and post-EECP treatment
within 1 week and the results were averaged: peak systolic velocity
(S-wave), peak early (E-wave) and late (A-wave) diastolic velocities,
end-systolic strain, peak systolic strain rate (Figure 3), and also
peak early (Ea) and late (Aa) diastolic annular velocities.
Statistics
Statistical analysis was conducted using SPSS software package
version 13 (SPSS Inc., Chicago, IL, USA). Data were expressed as
mean+SD. Data were tested for normal distribution with the
Kolmogorov–Smirnov test. The comparison of the differences
between the pre- and post-EECP groups was performed using the
paired samples t-test. The multiple comparisons were performed
with the ANOVA, and the comparison of the differences between
base and mid segment for the percentage of improvement was per-
formed with the independent samples t-test. A difference was con-
sidered signiﬁcant when the P, 0.05. Intra-observer variability was
assessed for peak systolic velocity, end-systolic strain, and peak sys-
tolic strain rate. Two segments were selected from each patient
randomly (total of 40 segments), and two measurements were
taken using the tissue velocity, strain, and strain rate methods on
the same segments. Intra-observer variability was deﬁned as the
differences between the measurements and expressed as a percen-
tage error of the means.
Results
Systolic function, diastolic function, and mitral
annulus measurements
The mean values of the echocardiographic data of systolic
and diastolic functions pre- and post-EECP treatment are
presented in Table 1. EECP therapy caused a signiﬁcant
Figure 3 Example of ventricular septum tissue Doppler imaging:
derivation of velocity (top), strain rate (middle), and strain
(bottom) from tissue Doppler data at basal septum (yellow), mid
septum (green), and apical segment (red). The series of velocity
and strain rate curves comprising systolic [S] and early and late dias-
tolic [E and A, respectively] components.
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improvement in LV diastolic function including increased
late diastolic transmitral inﬂow velocity (0.75+0.14 vs.
0.83+0.20 m/s, P, 0.05), propagation velocity (42.35+
6.25 vs. 46.00+5.68 cm/s, P , 0.05), and LV systolic func-
tion in terms of LVEF (40.25+12.72 vs. 46.25+12.97 cm/s,
P , 0.05) (Table 1).
Peak systolic and diastolic velocity results
The results of the mean and SDs of the peak systolic (S),
peak early diastolic (E), and peak late diastolic (A) velocity
measurements from the base and mid segments of the ven-
tricular septum, lateral, anterior, inferior, anteroseptal, and
posterior walls and also a comparison of the results pre- and
post-EECP therapy are presented in Figure 4. EECP therapy
brought about a signiﬁcant increase in peak systolic vel-
ocities in the entire LV base and mid segments (P , 0.05)
except for the lateral base, inferior base, posterior base,
and mid segments (PV ¼ NS). For peak early diastolic vel-
ocities, EECP therapy produced a signiﬁcant increase in
the entire base and mid segments (P , 0.05) except for
the lateral and anterior wall base segments (PV ¼ NS).
Additionally, EECP therapy caused a signiﬁcant increase in
peak late diastolic velocities in all the segments (P , 0.05)
except for the septum base, lateral base, posterior wall
base, and mid segments (PV ¼ NS).
Strain and strain rate results
The results of the mean and SDs of the end-systolic strain
and peak systolic strain rate measurements from the base
and mid segments of the ventricular septum, lateral,
anterior, inferior, anteroseptal, and posterior walls and
also a comparison of the results pre- and post-EECP
therapy are presented in Figure 5.
EECP therapy resulted in a signiﬁcant increase in the
end-systolic strain of the entire base and mid segments
Figure 4 Comparison of peak systolic velocity (A), peak early (B),
and late diastolic velocity measurements (C) (mean absolute+SD)
pre- and post-EECP therapy presented for all left ventricular base
and mid segments separately. Asterisks show that there are signiﬁ-
cant differences between the means (PV, 0.05). S, peak systolic
velocity; E, peak early diastolic velocity; A, peak late diastolic velo-
city; Sepb, basal segment of septum; Sepm, middle segment of
septum; Latb, basal segment of lateral wall; Latm, middle
segment of lateral wall; Antb, basal segment of anterior wall;
Antm, middle segment of anterior wall; Infb, basal segment of ante-
roseptal wall; Infm, middle segment of inferior wall; Ansb, basal
segment of anteroseptal wall; Ansm, middle segment of antero-
septal wall; Postb, basal segment of posterior wall; and Postm,
middle segment of posterior wall.
Table 1 Comparison of transmitral inﬂow velocity, pulmonary
ﬂow velocity and tissue Doppler data of mitral annulus (mean
absolute+ SD) pre-and post-EECP
Pre-EECP Post-EECP P-value
Transmitral spectral Doppler
E-velocity, m/s 0.77+0.28 0.75+0.27 NS
A-velocity, m/s 0.75+0.14 0.83+0.20a 0.030
DTE, ms 224.20+97.63 212.70+62.49 NS
IVRT, ms 99.35+27.03 97.62+25.14 NS
VP, cm/s 42.35+6.25 46.00+5.68a 0.012
Amdur 145.30+15.06 135.50+32.01 NS
E/A ratio 1.08+0.46 0.92+0.41a 0.037
Pulmonary spectral Doppler
PVs, cm/s 51.35+13.06 56.60+17.96 NS
PVd, cm/s 44.85+19.68 41.35+13.74 NS
Apvdur, ms 110.39+49.06 123.90+13.74 NS
Mitral annulus tissue Doppler
Ea-velocity, cm/s 5.35+1.79 5.95+1.10a 0.036
Aa-velocity, cm/s 6.85+2.16 6.75+1.37 NS
E/Ea ratio 15.44+6.96 12.61+4.22a 0.021
Left ventricular systolic function
LVEF, % 40.25+12.72 46.25+ 12.97a 0.000
aThe mean difference was signiﬁcant at the 0.05 level, NS, not signiﬁ-
cant; E-velocity, transmitral inﬂow peak E velocity; A-velocity, transmi-
tral inﬂow peak A velocity; DTE, deceleration time of transmitral ﬂow
E; IVRT, isovolumic relaxation time; VP, velocity of propagation; Amdur,
mitral A-wave duration; PVs, pulmonary peak systolic velocity; PVd, pul-
monary peak diastolic velocity; Apvdur, pulmonary A-wave duration;
Ea-velocity, mitral annulus peak early diastolic velocity; Aa-velocity,
mitrai annulus peak late diastolic velocity; LVEF, left ventricular ejection
fraction.
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(P, 0.05) except for the lateral base segment. There was
also a signiﬁcant increase in the end-systolic strain rate of
the entire base and mid LV segments (P , 0.05).
Mean systolic and diastolic peak velocity, strain, and
strain rate per region (basal and middle of the 12 LV seg-
ments) and SD were all calculated separately. These
results are depicted in Table 2.
There was a signiﬁcant reduction in NYHA anginal class
(1 angina class) for all the patients who completed
treatment.
Repeatability results
The mean differences for the intra-observer variability were
5.2, 4.7, and 6.2% for peak systolic velocity, end-systolic
strain, and peak systolic strain rate, respectively.
Discussion
Treatment of patients with refractory angina pectoris still con-
tinues to pose a challenge to themedical community. EECPhas
emerged in recent years as a non-invasive, well-tolerated
therapeutic option for CAD patients with refractory angina
not amenable to standard revascularization procedures.19
Indeed, prospective clinical trials and large treatment regis-
tries have shown major reductions in anginal symptoms and
improvements in objective measures of myocardial ischaemia
in response to EECP in patients with symptomatic CAD.2 More
recent studies have demonstrated the potential role of EECP
in heart failure management inasmuch as it improves quality
of life and reduces symptoms.6
EECP treatment is associated with an immediate increase
in the blood ﬂow in multiple vascular beds including the cor-
onary arterial circulation10 and causes acute changes in
haemodynamics including an increase in preload and a
decrease in afterload.10 Several published studies, designed
to assess objective evidence of improvement in myocardial
perfusion20 and beneﬁcial haemodynamic effects, showed
better various organ systems perfusion21,22 and LV diastolic
ﬁlling after EECP treatment23,24 and, accordingly, recom-
mended this modality as initial revascularization treatment
for angina refractory to medical therapy.25 The sudden
drop in intra-aortic pressure unloads the LV during systole,
thus reducing the work of the ventricle in ejecting blood
and reducing oxygen requirements of the cardiac
muscle.2,26 However, there have been no reports demon-
strating the quantitative regional function of myocardial
contractility.
The present study is the ﬁrst study on regional and global
LV systolic and diastolic functions in patients treated with
EECP for chronic stable refractory angina pectoris. In
addition to examining the motion of LV segments, which
are susceptible to tethering to the adjacent tissue, we
measured myocardial motion relative to the adjacent myo-
cardium using strain and strain rate curves. A comparison
of the tissue velocity, strain, and strain rate measurements
pre- and post-EECP for each segment is presented in
Figures 4 and 5. In the present study, total alteration (calcu-
lated for each parameter by averaging all LV base and mid
segments, Figure 6) showed that there was a higher signiﬁ-
cant alteration in strain rate when compared with the
strain and velocity measurements (P , 0.05). There was no
signiﬁcant difference between the total alterations of
peak systolic and early and late diastolic velocities statisti-
cally. The results of total alteration and also alteration in
LV walls are presented separately for each measured para-
meter in Figure 6. As regards which base or mid segments
have better function after EECP, our statistical comparisons
showed that there was no signiﬁcant difference between
Table 2 Comparison of TDI, Strain and Strain rate
measurements pre and post EECP (with mean absolute and
standard deviation)
Pre-EECP Post-EECP P-value
Tissue Doppler velocity
S-base, cm/s 3.86+0.47 3.93+0.38 NS
S-mid, cm/s 2.51+0.28 2.67+0.26a 0.045
E-base, cm/s 4.43+0.47 4.64+0.48 NS
E-mid, cm/s 3.24+0.18 3.52+0.26a 0.008
A-base, cm/s 4.48+0.58 4.75+0.70a 0.011
A-mid, cm/s 2.82+0.66 3.25+0.46a 0.009
End-systolic strain
Basal segments, % 11.64+1.51 13.97+1.52a 0.002
Middle segments, % 11.81+1.15 13.73+1.57a 0.000
Peak systolic strain rate
Basal segments, 1/s 0.76+0.07 0.99+0.08a 0.001
Middle segments, 1/s 0.75+0.09 0.94+0.09a 0.000
aThe mean difference was signiﬁcant at the 0.05 level, NS, not signiﬁ-
cant differences; S-base, peak systolic velocity of basal segments; S-mid,
peak systolic velocity of middle segments; E-base, peak systolic velocity
of basal segments; E-mid; peak systolic velocity of middle segments;
A-base; peak systolic velocity of basal segments; A-mid; peak systolic vel-
ocity of middle segments.
Figure 5 Comparison of strain (left) and strain rate (right) measurements (mean+SD) pre- and post-EECP therapy presented for all LV base
and mid segments separately. Asterisks show that there are signiﬁcant differences between the means (PV, 0.05).
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base and mid improvement for the velocity, strain, and
strain rate measurements.
In a study by Urano et al.27 in patients with stable refrac-
tory angina, EECP treatment did not alter systolic LV func-
tion, but it did signiﬁcantly improve the parameters of
ventricular diastolic function. Arora et al.28 did not see a
difference in these parameters but reported signiﬁcant
differences in LV systolic function between pre- and post-
EECP therapy measurements. We, however, saw signiﬁcant
differences in transmitral spectral late diastolic velocity,
propagation velocity, and E/A ratio for diastolic ventricular
function and also signiﬁcant differences in LV systolic func-
tion by LVEF measurement.
Given the ﬁndings of this study, EECP can beneﬁt patients
suffering from CAD by improving global and regional LV sys-
tolic and diastolic functions according to velocity, strain,
and strain rate imaging.
Study limitations
In this retrospective, non-randomized study, we evaluated the
immediate effects of EECP treatment within 1 week after the
completion of treatment for a relatively small number of
patients in NYHA Class III and IV angina. The long-term effects
of EECP therapy on myocardial function, however, require
further studies with larger sample populations and control
groups if possible persistent improvements inmyocardial func-
tion after EECP therapy are to be better documented.
In this study, we encountered some technical limitations.
Velocity, strain, and strain rate measurements are angle-
dependent and the angle between the ultrasound beam
and LV axis must be small.29 We manipulated the transducer
position to make the Doppler beam as parallel as possible to
the LV long-axis. Also, the velocity-regression technique has
a number of potential pitfalls. For instance, strain rate
curves are sensitive to signal noise and the quality of
these curves may vary depending on the care used in obtain-
ing the underlying velocity data.10,30 To minimize these dis-
advantages, we measured and averaged the parameters of
three consecutive cardiac cycles.
Conclusions
The present study showed the beneﬁcial effects of EECP on
both regional and global functions of the myocardium. EECP
improved systolic and diastolic parameters and caused sig-
niﬁcant alterations in longitudinal systolic and diastolic
Figure 6 Comparison of total peak systolic velocity (A), total peak early diastolic velocity (B), total peak late diastolic velocity (C), total
end-systolic strain (D), and total peak systolic strain rate (E) measurements, pre- and post-EECP therapy (mean+ SD). The middle lines show
alteration of the parameters for each wall separately. Total values calculated by average of all LV base and mid segments. Sep, septum wall;
Lat, lateral wall; Ant, anterior wall; Inf, inferior wall; Ans, anteroseptal wall; Post, posterior wall.
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myocardial functions as assessed by colour tissue Doppler
imaging in patients with chronic angina pectoris. EECP is
an effective, non-invasive therapy for CAD.
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